乳腺导管原位癌伴微浸润的临床特征：一项叙述性综述。
Clinical characteristics of breast ductal carcinoma in situ with microinvasion: a narrative review.
作者信息
Zheng Jie, Yu Jingjing, Zhou Tao
机构信息
Department of Breast Cancer Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Division of Gland Sugery, The Third Hospital of Xingtai, Xingtai, China.
出版信息
J Int Med Res. 2020 Nov;48(11):300060520969304. doi: 10.1177/0300060520969304.
Abstract
Ductal carcinoma in situ (DCIS) with microinvasion (DCIS-MI) is defined as the extension of cancer cells beyond the basement membrane into adjacent tissue with no focus larger than 1 mm or a maximum diameter of less than 1 mm for multiple invasive foci. DCIS-MI constitutes approximately 1% of all breast cancer cases and 5% to 10% of cases of DCIS. The current literature is controversial concerning the clinical prognostic features and management of DCIS-MI. This narrative review described recently reported literature regarding the characteristics, diagnosis, treatment, and prognosis of DCIS-MI.
摘要
伴有微浸润的导管原位癌（DCIS-MI）定义为癌细胞突破基底膜延伸至邻近组织，且最大浸润灶直径不超过1毫米，若存在多个浸润灶，则其最大直径之和小于1毫米。DCIS-MI约占所有乳腺癌病例的1%，占DCIS病例的5%至10%。目前关于DCIS-MI的临床预后特征及治疗方法的文献存在争议。本叙述性综述介绍了近期报道的有关DCIS-MI的特征、诊断、治疗及预后的文献。
相似文献
1
Clinical characteristics of breast ductal carcinoma in situ with microinvasion: a narrative review.乳腺导管原位癌伴微浸润的临床特征：一项叙述性综述。
J Int Med Res. 2020 Nov;48(11):300060520969304. doi: 10.1177/0300060520969304.
2
Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer.乳腺导管原位癌、导管原位癌伴微浸润和浸润性乳腺癌的不同分布。
World J Surg Oncol. 2012 Dec 8;10:262. doi: 10.1186/1477-7819-10-262.
3
Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.伴有微浸润的乳腺导管原位癌：一项对1248例连续切片导管癌的长期研究支持的定义。
Cancer. 2002 Apr 15;94(8):2134-42. doi: 10.1002/cncr.10451.
4
Prognostic significance of microinvasion with ductal carcinoma in situ of the breast: a meta-analysis.乳腺导管原位癌微浸润的预后意义：一项荟萃分析。
Breast Cancer Res Treat. 2023 Jan;197(2):245-254. doi: 10.1007/s10549-022-06800-3. Epub 2022 Nov 24.
5
Clinicopathological characteristics, treatments, and prognosis of breast ductal carcinoma in situ with microinvasion: A narrative review.伴微浸润的乳腺导管原位癌的临床病理特征、治疗及预后：一项叙述性综述
Chronic Dis Transl Med. 2022 Nov 26;9(1):5-13. doi: 10.1002/cdt3.53. eCollection 2023 Mar.
6
Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.不同亚型乳腺癌在乳腺导管原位癌（DCIS）、微浸润性 DCIS 和伴有浸润成分的 DCIS 中的分布情况。
Ann Surg Oncol. 2011 May;18(5):1342-8. doi: 10.1245/s10434-010-1407-3. Epub 2010 Nov 2.
7
More microinvasive foci in larger tumours of breast ductal carcinoma .乳腺导管癌中较大肿瘤内有更多微小浸润灶。
Singapore Med J. 2023 Aug;64(8):493-496. doi: 10.11622/smedj.2022089.
8
Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery.多灶微浸润与保乳手术后导管原位癌女性浸润性局部复发风险增加相关。
Breast Cancer Res Treat. 2019 Nov;178(1):169-176. doi: 10.1007/s10549-019-05364-z. Epub 2019 Jul 19.
9
Ductal carcinoma in situ with microinvasion: clinicopathologic study and biopathologic profile.伴有微浸润的导管原位癌：临床病理研究及生物病理特征
Pathol Res Pract. 2006;202(3):131-5. doi: 10.1016/j.prp.2006.01.001. Epub 2006 Feb 3.
10
Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion.伴有微浸润的乳腺导管原位癌的生物学行为及长期预后
Oncotarget. 2016 Sep 27;7(39):64182-64190. doi: 10.18632/oncotarget.11639.
引用本文的文献
1
Ductal Carcinoma In Situ of the Breast in Sclerosing Adenosis Mimicking Microinvasive Ductal Carcinoma: A Rare Case Report.硬化性腺病中酷似微浸润性导管癌的乳腺导管原位癌：1例罕见病例报告
Clin Case Rep. 2024 Dec 12;12(12):e9639. doi: 10.1002/ccr3.9639. eCollection 2024 Dec.
2
Unveiling the Clinical Path of Microinvasive Breast Cancer: A Comparative Study With Tis-T1 Breast Cancer.揭示微创乳腺癌的临床路径：Tis-T1 乳腺癌的对比研究。
Cancer Med. 2024 Oct;13(19):e70297. doi: 10.1002/cam4.70297.
3
A clinical radiomics nomogram preoperatively to predict ductal carcinoma in situ with microinvasion in women with biopsy-confirmed ductal carcinoma in situ: a preliminary study.术前临床放射组学列线图预测经活检证实为导管原位癌的女性伴微浸润的导管原位癌：初步研究。
BMC Med Imaging. 2023 Sep 7;23(1):118. doi: 10.1186/s12880-023-01092-5.
4
Clinicopathological characteristics, treatments, and prognosis of breast ductal carcinoma in situ with microinvasion: A narrative review.伴微浸润的乳腺导管原位癌的临床病理特征、治疗及预后：一项叙述性综述
Chronic Dis Transl Med. 2022 Nov 26;9(1):5-13. doi: 10.1002/cdt3.53. eCollection 2023 Mar.
5
Microinvasive breast cancer and the role of sentinel lymph node biopsy.微浸润性乳腺癌与前哨淋巴结活检的作用。
Sci Rep. 2022 Jul 20;12(1):12391. doi: 10.1038/s41598-022-16521-8.
6
Clinicopathological characteristics and prognosis of microinvasive breast cancer: A population-based analysis.基于人群的分析：微浸润性乳腺癌的临床病理特征和预后。
Cancer Med. 2022 Dec;11(23):4501-4512. doi: 10.1002/cam4.4839. Epub 2022 May 22.
7
Diallyl Trisulfide Induces Apoptosis in Breast Ductal Carcinoma In Situ Derived and Minimally Invasive Breast Cancer Cells.二烯丙基三硫诱导乳腺导管原位癌和微浸润乳腺癌细胞凋亡。
Nutrients. 2022 Mar 31;14(7):1455. doi: 10.3390/nu14071455.
本文引用的文献
1
Differences in pathologic characteristics between ductal carcinoma in situ (DCIS), DCIS with microinvasion and DCIS with invasive ductal carcinoma.导管原位癌（DCIS）、微浸润性DCIS和浸润性导管癌伴DCIS之间的病理特征差异。
Int J Clin Exp Pathol. 2020 May 1;13(5):1066-1072. eCollection 2020.
2
Role of Sentinel Lymph Node Biopsy in Microinvasive Breast Cancer.前哨淋巴结活检在微小浸润性乳腺癌中的作用。
Ann Surg Oncol. 2020 Oct;27(11):4468-4473. doi: 10.1245/s10434-020-08606-3. Epub 2020 May 19.
3
Long term prognosis of ductal carcinoma with microinvasion: a retrospective cohort study.伴有微浸润的导管癌的长期预后：一项回顾性队列研究。
Int J Clin Exp Pathol. 2018 May 1;11(5):2665-2674. eCollection 2018.
4
Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ.前哨淋巴结活检在微浸润性导管原位癌中的应用。
Br J Surg. 2019 Mar;106(4):375-383. doi: 10.1002/bjs.11079. Epub 2019 Feb 21.
5
Microinvasive Carcinoma versus Ductal Carcinoma : A Comparison of Clinicopathological Features and Clinical Outcomes.微浸润癌与导管癌：临床病理特征及临床结局比较
J Breast Cancer. 2018 Jun;21(2):197-205. doi: 10.4048/jbc.2018.21.2.197. Epub 2018 Jun 20.
6
Breast-conserving surgery followed by whole-breast irradiation offers survival benefits over mastectomy without irradiation.保乳手术联合全乳放疗比乳房切除术不联合放疗更能提高生存获益。
Br J Surg. 2018 Nov;105(12):1607-1614. doi: 10.1002/bjs.10889. Epub 2018 Jun 21.
7
Clinicopathologic analysis of a large series of microinvasive breast cancers.大量微浸润性乳腺癌的临床病理分析
Breast J. 2018 Jul;24(4):574-579. doi: 10.1111/tbj.13001. Epub 2018 Feb 24.
8
Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ.微浸润对导管原位癌女性乳腺癌死亡率的影响。
Breast Cancer Res Treat. 2018 Feb;167(3):787-795. doi: 10.1007/s10549-017-4572-2. Epub 2017 Nov 8.
9
Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ.年轻女性导管原位癌的治疗模式和临床结局趋势。
Clin Breast Cancer. 2018 Apr;18(2):e179-e185. doi: 10.1016/j.clbc.2017.08.001. Epub 2017 Aug 10.
10
Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?是否存在T1至T2期、淋巴结阴性的乳腺癌患者，其局部区域疾病复发的风险为“高风险”？
Cancer. 2017 Jul 15;123(14):2626-2633. doi: 10.1002/cncr.30658. Epub 2017 Mar 23.
Zotero 插件